MoneyWorks4Me

Morepen Laboratories informs about clarification

11 Apr 2022 Evaluate
Morepen Laboratories has clarified that there are no pending announcements, events or information which is/are price sensitive that could have led to significant movement in price in the company's shares. The movement in price in the shares may be market driven. 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..